J Tilman Gerlach

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. ncbi Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance
    J Tilman Gerlach
    Medical Department II, Klinikum Grosshadern and Institute for Immunology, Schwabing, Munich, Germany
    Gastroenterology 125:80-8. 2003
  2. ncbi FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C
    Malte H J Heeg
    Medical Department II and Institute for Immunology, Ludwig Maximilians University Munich, Munich, Germany
    Gastroenterology 137:1280-8.e1-6. 2009
  3. ncbi Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection
    Axel Ulsenheimer
    Institute for Immunology, Klinikum Grosshadern, University of Munich, Munich, Germany
    Hepatology 41:643-51. 2005
  4. ncbi Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment
    Markus Backmund
    Department of Addiction Medicine, General Hospital Munich Schwabing, Munich, Germany
    Clin Infect Dis 40:S330-5. 2005
  5. ncbi Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C
    Daniel Steinmann
    Department of Medicine II, University of Freiburg, Freiburg, Germany
    J Virol 78:9030-40. 2004
  6. ncbi Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C
    Axel Ulsenheimer
    Institute for Immunology, University of Munich, Germany
    Hepatology 37:1189-98. 2003

Collaborators

Detail Information

Publications6

  1. ncbi Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance
    J Tilman Gerlach
    Medical Department II, Klinikum Grosshadern and Institute for Immunology, Schwabing, Munich, Germany
    Gastroenterology 125:80-8. 2003
    ..The aim of this study was to define the natural course of the disease and to contribute to the development of treatment strategies for acute hepatitis C virus...
  2. ncbi FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C
    Malte H J Heeg
    Medical Department II and Institute for Immunology, Ludwig Maximilians University Munich, Munich, Germany
    Gastroenterology 137:1280-8.e1-6. 2009
    ..FOXP3(+)CD25(+)CD4(+) regulatory T cells can modulate HCV-specific immune responses in vitro, but the role of virus-specific regulatory T cells in the pathogenesis of chronic viral persistence is unknown...
  3. ncbi Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection
    Axel Ulsenheimer
    Institute for Immunology, Klinikum Grosshadern, University of Munich, Munich, Germany
    Hepatology 41:643-51. 2005
    ..In cHC there is incomplete recovery of pDC function, which, however, could be solely due to the chronic inflammatory state...
  4. ncbi Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment
    Markus Backmund
    Department of Addiction Medicine, General Hospital Munich Schwabing, Munich, Germany
    Clin Infect Dis 40:S330-5. 2005
    ..All studies dealing with treatment for HCV infection in IDUs have stressed the necessity of collaboration among hepatologists and specialists in addiction medicine, social workers, and psychotherapists...
  5. ncbi Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C
    Daniel Steinmann
    Department of Medicine II, University of Freiburg, Freiburg, Germany
    J Virol 78:9030-40. 2004
    ....
  6. ncbi Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C
    Axel Ulsenheimer
    Institute for Immunology, University of Munich, Germany
    Hepatology 37:1189-98. 2003
    ..In conclusion, functional changes of HCV-specific CD4(+) T cells or failure to develop a long-lasting T-helper response may contribute to chronic hepatitis C viral persistence...